The short answer
It is not established that Herba Taraxaci adds to torsemide-related low blood pressure or requires a fixed dosing gap. The available dandelion evidence concerns different preparations and does not test this combination.
What this answer covers
Herba Taraxaci herb-material entry; confirm species and parts. Fresh leaf extract and root-with-herb are not automatically the same product.
- Supplement or preparation
- Herba Taraxaci
- Medication ingredient
- torsemide
Traditional urinary use does not prove hypotension
The European monograph concerns dandelion root combined with herb and reports no interactions. Its urinary-flushing use is traditional and does not demonstrate a blood-pressure interaction with torsemide.
The leaf pilot has narrow findings
A small uncontrolled study tested fresh leaf extract for one day. Some urinary measures increased after the first two doses, with no change after the third. It did not test torsemide, low blood pressure or the full range of Herba Taraxaci products.
Fluid balance is still worth reviewing
Torsemide’s effects can become excessive and cause dehydration or hypotension. This supports checking a product intended to increase urination, without converting an uncertain herb effect into proven additive hypotension.
No proven spacing rule
A short dosing gap has not been shown to prevent a possible fluid effect. Tell the treating team about new urinary or weight-loss products, dizziness, faintness, marked thirst or reduced fluid intake. Torsemide can itself cause excess fluid loss and kidney problems. Follow your existing fluid plan rather than increasing fluids or changing torsemide on your own.
Evidence and practical considerations
Timing & monitoring
No verified separation interval or universal avoidance for this exact herb identity.
- Exact scope
- Herba Taraxaci herb-material entry; confirm species and parts. Fresh leaf extract and root-with-herb are not automatically the same product. with Oral torsemide, exact RxCUI38413 IN; not all loop diuretics or parenteral exposure.
- Medication form and route
- oral torsemide; oral supplement
What remains uncertain
- Source-specific identity and endpoint limits apply; no unstudied dosing recommendation.
Factors that may matter: Dose and duration; Kidney function; Exact preparation; Other medicines.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed oral torsemide for edema or hypertension.
Excess diuresis may cause dehydration, hypotension and worsening renal function. Electrolyte abnormalities include hypokalemia; monitor serum electrolytes. Low-dose hypertension studies showed small average potassium decreases, with no universal deficiency. Photosensitivity appears among postmarketing reports.
How this applies: Interpret only for the stated species, preparation, route and endpoints; exact torsemide pair evidence is distinguished.
No named botanical interaction for this batch. Postmarketing reports cannot establish frequency or causality. Potassium replacement is not required for every patient.
Source 2: regulatory guidance
ema.europa.eu · Source check Sep 10, 2026
Population: People using the specified oral preparation.
Traditional urinary-flushing use; no interactions reported.
How this applies: Interpret only for the stated species, preparation, route and endpoints; exact torsemide pair evidence is distinguished.
Not identical to Herba Taraxaci alone and not proof of torsemide-associated hypotension.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 17 volunteers.
Urination frequency increased after the first dose and urine-to-fluid ratio after the second; no change after the third dose.
How this applies: Interpret only for the stated species, preparation, route and endpoints; exact torsemide pair evidence is distinguished.
Uncontrolled pilot, no torsemide or blood-pressure interaction endpoint; leaf extract is not every Herba Taraxaci product.
Research assessment: · Open full citations ↗
Side effects & toxicity
Related urinary observations do not establish additive torsemide hypotension and have preparation mismatches.
- Exact scope
- Herba Taraxaci herb-material entry; confirm species and parts. Fresh leaf extract and root-with-herb are not automatically the same product. with Oral torsemide, exact RxCUI38413 IN; not all loop diuretics or parenteral exposure.
- Medication form and route
- oral torsemide; oral supplement
What remains uncertain
- Source-specific identity and endpoint limits apply; no unstudied dosing recommendation.
Factors that may matter: Dose and duration; Kidney function; Exact preparation; Other medicines.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed oral torsemide for edema or hypertension.
Excess diuresis may cause dehydration, hypotension and worsening renal function. Electrolyte abnormalities include hypokalemia; monitor serum electrolytes. Low-dose hypertension studies showed small average potassium decreases, with no universal deficiency. Photosensitivity appears among postmarketing reports.
How this applies: Interpret only for the stated species, preparation, route and endpoints; exact torsemide pair evidence is distinguished.
No named botanical interaction for this batch. Postmarketing reports cannot establish frequency or causality. Potassium replacement is not required for every patient.
Source 2: regulatory guidance
ema.europa.eu · Source check Sep 10, 2026
Population: People using the specified oral preparation.
Traditional urinary-flushing use; no interactions reported.
How this applies: Interpret only for the stated species, preparation, route and endpoints; exact torsemide pair evidence is distinguished.
Not identical to Herba Taraxaci alone and not proof of torsemide-associated hypotension.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 17 volunteers.
Urination frequency increased after the first dose and urine-to-fluid ratio after the second; no change after the third dose.
How this applies: Interpret only for the stated species, preparation, route and endpoints; exact torsemide pair evidence is distinguished.
Uncontrolled pilot, no torsemide or blood-pressure interaction endpoint; leaf extract is not every Herba Taraxaci product.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Prepared exact-pair article with preparation boundaries and qualified current-claim conclusions. | |
| Research summary published |
Article revision: 88394de3fe6efc17
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.